Market News & Trends
Rani Therapeutics Secures Funding Led by Google Ventures
Rani Therapeutics recently announced it has closed its Series B round of funding, led by Google Ventures. InCube Ventures, a life sciences venture fund that…
Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
Cost benefits and pharmaceutical companies’ desire to focus on their core competencies has created an increasing need for outsourcing and spurred the global pharmaceutical contract…
Baxter International & Coherus Biosciences Sign $246-Million Pact
Baxter International Inc. and Coherus Biosciences, Inc. recently announced they have entered into an exclusive collaboration to develop and commercialize a biosimilar to etanercept for…
Endo Health Solutions Pays $225 Million for Boca Pharmacal
Endo Health Solutions recently announced that its Qualitest subsidiary has reached a definitive agreement to acquire privately held Boca Pharmacal, a specialty generics company, for…
FDA Approves Third Drug in BD Simplist Prefilled Injectable Line of Products
BD Rx Inc., a wholly owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company), recently announced the US FDA has approved…
Sangamo BioSciences to Acquire Biotechnology Company
Sangamo BioSciences, Inc. recently announced it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus (AAV)…
Frost & Sullivan: Competition Intensifies as Pharma Companies Race to Launch Type 2 Diabetes Drugs
The global pre-diabetes population is three times the size of the current diabetes patient population. A tremendous increase in the pandemic’s prevalence is in store,…
CRO Market Grows Significantly; BRIC Regions Represent Huge Untapped Opportunity
The total combined peer group revenue from Contract Research Organizations (CROs) increased by 10.2% year-to-year, from $12.4 billion in 2011 to $13.6 billion in 2012,…
Syndax Pharmaceuticals Receives $26.6 Million for Final Stage Push With Cancer Drug
Syndax Pharmaceuticals Inc., which is developing epigenetic therapies for treatment-resistant cancers, recently announced it has secured a $26.6 million Series B financing. Participating investors included…
Catalyst Pharmaceutical Partners Gets Breakthrough Therapy Designation, Stock Soars 41.55%
Catalyst Pharmaceutical Partners, Inc. recently announced its investigational product Firdapse (amifampridine phosphate) has received Breakthrough Therapy Designation by the US FDA for the symptomatic treatment…
Pfizer’s Lung Cancer Drug Rejected; Deemed Too Costly
Pfizer Ltd has expressed concern and disappointment that the final appraisal determination (FAD) from the National Institute of Health and Care Excellence (NICE) does not…
Fresenius Kabi Enters Joint Venture With PT Soho Global Health
Fresenius Kabi has formed a joint venture with PT Soho Global Health, a leading Indonesian pharmaceutical company, acquiring a 51% stake in its PT Ethica…
Adimab Partners With Celgene Corporation
Adimab, LLC recently announced a multi-target discovery collaboration with Celgene Corporation of Summit, NJ. Under terms of the agreement, Adimab will use its proprietary platform…
InSite Vision Announces Patent Issuance on Ophthalmic Delivery System
InSite Vision Incorporated recently announced the United States Patent and Trademark Office (USPTO) has issued US Patent No. 8,501,800 on the company’s DuraSite 2 next-generation…
Foamix Celebrates Receiving 20th US Patent
Foamix Ltd. recently announced the United States Patent and Trademark Office has granted US Patent No. 8,512,718, Pharmaceutical Composition For Topical Application, describing, inter alia,…
MannKind Satisfies Conditions for $40 Million
MannKind Corporation recently announced that pursuant to a Facility Agreement dated July 1, 2013, between Deerfield Private Design Fund II, L.P. and Deerfield Private Design…
West Introduces the Daikyo D4 Elastomer Formulation
West Pharmaceutical Services, Inc. and partner Daikyo Seiko, Ltd. recently announced the commercial launch of the Daikyo D4 elastomer formulation. To meet the ever-increasing quality…
MultiCell Technologies & Genisphere Evaluate Targeted Delivery of MCT-485 for Cancer
MultiCell Technologies, Inc. and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of liver cancer. MCT-485 is a…
Bio-Path Holdings’ Liposomal Delivery Technology Achieves Major Milestone
Bio-Path Holdings, Inc. recently announced that a scientific assay has confirmed that its lead product candidate BP-100-1.01 (Liposomal Grb-2) inhibits the disease-causing target protein in…
XstalBio Launches CentuRecon to Accelerate the Delivery of Biologic Drugs
XstalBio Ltd recently announced the launch of CentuRecon, a new patented reconstitution technology that has the potential to revolutionize the preparation of high concentration protein…
